ETORICOXIB IS A NEW SELECTIVE CYCLOOXYGENASE-2 INHIBITOR
The paper provides the clinical characteristics of etoricoxib (Arcoxia), a new selective cyclooxygenase-2 inhibitor having unique properties, which permits it to be distinguished among other nonsteroidal anti-inflammatory agents.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2009-06-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/229 |